EFSA addresses topic-specific health claims
This article was originally published in The Tan Sheet
Executive Summary
The European Food Safety Authority schedules a series of online consultations and public meetings on health claims in specific areas, beginning with a Dec. 2 meeting on the scientific substantiation needed for gut and immune function claims. The authority says a draft guidance on gut and immunity claims it will publish in October will be discussed, along with public comments, at the meeting in Amsterdam. Food industry scientists and other stakeholders can anticipate sessions on claims relating to weight management, oxidative damage, cardiovascular health and cognitive function planned for 2011 and 2012. EFSA seeks to engage with stakeholders to clarify expectations for claim substantiation (1"The Tan Sheet" April 26, 2010, In Brief)
You may also be interested in...
EFSA to discuss health claims
The European Food Safety Authority schedules a June 1 technical meeting to provide an update on its ongoing nutrition and health claim evaluation and an opportunity for industry stakeholders to engage with experts from the Scientific Panel on Dietetic Products, Nutrition and Allergies, which evaluates the claims submitted by EU member states. EFSA said the meeting in Parma, Italy, also will review the general conditions, scientific criteria and pertinent studies for claim substantiation. Europe's nutritional products industry likely will seek clarity from EFSA on the claims evaluation process at the meeting, given the prevalence of negative opinions issued thus far and the sentiment held by many in industry that the criteria for claims are too rigid (1"The Tan Sheet" March 1, 2010, In Brief)
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.